Opexa Therapeutics, Inc. 4
4 · Opexa Therapeutics, Inc. · Filed Mar 4, 2015
Insider Transaction Report
Form 4
Radhakrishnan Karthik
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2015-03-02+50,000→ 50,000 totalExercise: $0.82Exp: 2025-03-02→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]25% vests on the one-year anniversary of the date of grant and the balance vests quarterly over the remaining three years.